Redecol Limited’s board appoints Hyman Capital as advisor to its fund raising activities

The Board of Redecol Limited has pleasure in announcing it is approaching the private market to raise £ 2m to fund clinical trials and then take the product to market. The board has selected Hyman Capital to advise on this process.

Redecol Limited has been established to research, develop and commercialise unique sensor technology for the monitoring and managing of asthma and other chronic respiratory conditions which will radically improve patient’s lives and reduce the cost burden of these chronic diseases for health service providers.

Redecol Limited is excited to report that they have appointed Hyman Capital as advisor to its fund-raising activities. Redecol Limited is working with Hyman Capital, to identify potential investors to raise the £ 2m.

Graham Hine said, “We selected Hyman Capital because of their strong record of raising funding to grow successful businesses and also because they understand the potential of Redecol to help improve the lives of millions of asthma sufferers.”

Clive Hyman said, “We are glad to be working with Redecol Limited, we have taken the time to understand the business and are working hand in glove with the management team to explain the benefits of their invention in their materials.”

Enquiries welcomed:

Graham Hine, Redecol Limited – +44 (0) 7774 257 333

Clive Hyman, Hyman Capital – +44 (0)7388 245 446

Notes to Editors

Redecol
https://www.redecol.co.uk/

Redecol is a medtech company who are dedicated to developing easy-to-use, low cost respiratory devices, designed to provide actionable lung function information to people with asthma and COPD, enabling them to manage their own medication.

Their devices will reduce morbidity, mortality and overall healthcare costs through utilising unique technology to monitor respirate levels in patients to accurately diagnose conditions and monitor the effectiveness of treatment on patients over a period of time.

Hyman Capital
www.hymancapital.com

Clive Hyman is the Founder, Chair and CEO of Hyman Capital. He is a serial Chairman, non-executive, CEO. and CFO with cash management, operational and M&A experience. He established the firm in 2005.

The firm’s aim is to fill the funding gap for growth businesses by providing expert advice to access new sources of funding and to fully prepare for any transactions they are planning to undertake. It also advises clients on acquiring or disposing of a business, and how businesses can be more efficient and effective.

Hyman Capital has an experienced team offering cross-sector and cross-border expertise, which exists to help clients create value.


Attached Media


Press Contacts